CRCA vs. IBMO
CRCA (ProShares Ultra CRCL) and IBMO (iShares iBonds Dec 2026 Term Muni Bond ETF) are both exchange-traded funds - CRCA is a Leveraged Equities fund actively managed by ProShares, while IBMO is a Municipal Bonds fund tracking the S&P AMT-Free Municipal Series Callable-Adjusted Dec 2026 Index. CRCA is actively managed, while IBMO is passively managed. At a correlation of -0.09, they often move in opposite directions. CRCA charges 0.95%/yr vs 0.18%/yr for IBMO.
Performance
CRCA vs. IBMO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -50.19% return, which is significantly lower than IBMO's 1.03% return.
CRCA
- 1D
- -10.71%
- 1M
- -58.97%
- YTD
- -50.19%
- 6M
- -54.34%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IBMO
- 1D
- 0.02%
- 1M
- 0.19%
- YTD
- 1.03%
- 6M
- 1.02%
- 1Y
- 2.62%
- 3Y*
- 2.80%
- 5Y*
- 0.72%
- 10Y*
- —
CRCA vs. IBMO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -50.19% | -84.67% |
IBMO iShares iBonds Dec 2026 Term Muni Bond ETF | 1.03% | 1.07% |
Correlation
The correlation between CRCA and IBMO is -0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 7, 2025 | -0.09 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. IBMO — Risk / Return Rank
CRCA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
IBMO
CRCA vs. IBMO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and iShares iBonds Dec 2026 Term Muni Bond ETF (IBMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRCA | IBMO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.49 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 6.95 | — |
| Martin ratioReturn relative to average drawdown | — | 20.64 | — |
Loading charts...
Drawdowns
CRCA vs. IBMO - Drawdown Comparison
The maximum CRCA drawdown since its inception was -94.31%, which is greater than IBMO's maximum drawdown of -14.77%. Use the drawdown chart below to compare losses from any high point for CRCA and IBMO.
Loading charts...
Drawdown Indicators
| CRCA | IBMO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.31% | -14.77% | -79.54% |
Max Drawdown (1Y)Largest decline over 1 year | — | -0.38% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -1.76% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -8.86% | — |
Current DrawdownCurrent decline from peak | -92.37% | 0.00% | -92.37% |
Average DrawdownAverage peak-to-trough decline | -71.73% | -2.31% | -69.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 0.13% | — |
Volatility
CRCA vs. IBMO - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | IBMO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 0.22% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 0.79% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 194.67% | 1.10% | +193.57% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 194.67% | 2.14% | +192.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 194.67% | 4.50% | +190.17% |
CRCA vs. IBMO - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is higher than IBMO's 0.18% expense ratio.
Dividends
CRCA vs. IBMO - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 3.48%, more than IBMO's 2.39% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
CRCA ProShares Ultra CRCL | 3.48% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IBMO iShares iBonds Dec 2026 Term Muni Bond ETF | 2.39% | 2.37% | 2.15% | 1.65% | 0.89% | 0.62% | 1.03% | 1.01% |
Frequently Asked Questions
CRCA and IBMO have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, IBMO is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
IBMO is cheaper with a 0.18% expense ratio, compared with 0.95% for CRCA.
CRCA has the higher dividend yield at 3.48%, compared with 2.39% for IBMO.
CRCA is categorized as Leveraged Equities, while IBMO is Municipal Bonds. They also come from different issuers: ProShares and iShares. Their fees differ too: 0.95% for CRCA and 0.18% for IBMO.
Find the right allocation for CRCA and IBMO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer